MRNA: Moderna, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 13,210.89
Enterprise Value ($M) 11,283.89
Book Value ($M) 10,901.00
Book Value / Share 28.20
Price / Book 1.21
NCAV ($M) 4,858.00
NCAV / Share 12.57
Price / NCAV 2.72

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -0.19
Return on Equity (ROE) -0.26

Liquidity (mrq)
Quick Ratio 3.62
Current Ratio 3.67

Balance Sheet (mrq) ($M)
Current Assets 8,099.00
Assets 14,142.00
Liabilities 3,241.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3,236.00
Operating Income -3,945.00
Net Income -3,561.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -3,004.00
Cash from Investing 1,949.00
Cash from Financing 56.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A Baillie Gifford & Co 10.10 -14.82
04-10 13G/A Vanguard Group Inc 10.20 15.13

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-25 1,106,790 5,944,534 18.62
2025-03-24 2,800,280 8,184,770 34.21
2025-03-21 1,269,581 5,535,411 22.94

(click for more detail)

Similar Companies
MIST – Milestone Pharmaceuticals Inc. MLYS – Mineralys Therapeutics, Inc.
MNMD – Mind Medicine (MindMed) Inc. MRSN – Mersana Therapeutics, Inc.
MRVI – Maravai LifeSciences Holdings, Inc.


Financial data and stock pages provided by
Fintel.io